Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease
合并强直性脊柱炎会增加使用生物制剂或小分子疗法控制炎症性肠病的风险。
期刊:Intestinal Research
影响因子:3.9
doi:10.5217/ir.2022.00057
Jun, Yu Kyung; Yoon, Hyuk; Koh, Seong-Joon; Kim, A Hyeon; Kim, Kwang Woo; Park, Jun Won; Lee, Hyun Jung; Kang, Hyoun Woo; Im, Jong Pil; Park, Young Soo; Kim, Joo Sung
